Da An Gene Co Ltd of Sun Yat-Sen University
Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through two segments, Biological Products and Related Business and Financial Business. The company offers reagents for hepatitis virus, sexually transmitted infections, blood screening, digestive pathogens, coro… Read more
Da An Gene Co Ltd of Sun Yat-Sen University (002030) - Total Liabilities
Latest total liabilities as of September 2025: CN¥1.10 Billion CNY
Based on the latest financial reports, Da An Gene Co Ltd of Sun Yat-Sen University (002030) has total liabilities worth CN¥1.10 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Da An Gene Co Ltd of Sun Yat-Sen University - Total Liabilities Trend (2001–2024)
This chart illustrates how Da An Gene Co Ltd of Sun Yat-Sen University's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Da An Gene Co Ltd of Sun Yat-Sen University Competitors by Total Liabilities
The table below lists competitors of Da An Gene Co Ltd of Sun Yat-Sen University ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shenzhen Sunrise New Energy Co Ltd
SHE:002256
|
China | CN¥537.86 Million |
|
Genco Shipping & Trading Ltd
NYSE:GNK
|
USA | $220.30 Million |
|
Shanghai Tofflon Science Tech
SHE:300171
|
China | CN¥5.21 Billion |
|
NCAB Group
ST:NCAB
|
Sweden | Skr2.08 Billion |
|
ASA Gold and Precious Metals Ltd
NYSE:ASA
|
USA | $2.11 Million |
|
BioLife Solutions Inc
NASDAQ:BLFS
|
USA | $34.00 Million |
|
Shanghai SMI Holding Co Ltd
SHG:600649
|
China | CN¥63.88 Billion |
|
Noah Holdings Ltd
NYSE:NOAH
|
USA | $1.65 Billion |
Liability Composition Analysis (2001–2024)
This chart breaks down Da An Gene Co Ltd of Sun Yat-Sen University's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Da An Gene Co Ltd of Sun Yat-Sen University's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Da An Gene Co Ltd of Sun Yat-Sen University (2001–2024)
The table below shows the annual total liabilities of Da An Gene Co Ltd of Sun Yat-Sen University from 2001 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.43 Billion | -22.94% |
| 2023-12-31 | CN¥1.86 Billion | -40.76% |
| 2022-12-31 | CN¥3.14 Billion | +17.36% |
| 2021-12-31 | CN¥2.68 Billion | +22.47% |
| 2020-12-31 | CN¥2.19 Billion | +48.25% |
| 2019-12-31 | CN¥1.47 Billion | +0.78% |
| 2018-12-31 | CN¥1.46 Billion | -26.87% |
| 2017-12-31 | CN¥2.00 Billion | +26.07% |
| 2016-12-31 | CN¥1.59 Billion | +43.96% |
| 2015-12-31 | CN¥1.10 Billion | +63.13% |
| 2014-12-31 | CN¥675.55 Million | +70.13% |
| 2013-12-31 | CN¥397.08 Million | +38.80% |
| 2012-12-31 | CN¥286.08 Million | +23.75% |
| 2011-12-31 | CN¥231.17 Million | +20.77% |
| 2010-12-31 | CN¥191.41 Million | +22.25% |
| 2009-12-31 | CN¥156.57 Million | +8.29% |
| 2008-12-31 | CN¥144.59 Million | +23.88% |
| 2007-12-31 | CN¥116.72 Million | +157.16% |
| 2006-12-31 | CN¥45.39 Million | +67.17% |
| 2005-12-31 | CN¥27.15 Million | -51.73% |
| 2004-12-31 | CN¥56.25 Million | -33.31% |
| 2003-12-31 | CN¥84.35 Million | +37.12% |
| 2002-12-31 | CN¥61.51 Million | +25.01% |
| 2001-12-31 | CN¥49.21 Million | -- |